Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.23
-0.44 (-1.71%)
At close: Oct 6, 2026, 4:00 PM EDT
24.89
-0.34 (-1.35%)
Pre-market: Oct 7, 2026, 7:02 AM EDT

Beam Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-86.52-79.99-376.74-132.53-289.09-370.64
Depreciation & Amortization
22.2422.2921.9320.0114.157.45
Asset Writedown & Restructuring Costs
14.5114.51---154.95
Loss (Gain) From Sale of Investments
-270.02-274.65-8.67-11.15-29.61-17.77
Loss (Gain) on Equity Investments
----25.5-
Stock-Based Compensation
81.5294.24120.6698.6584.3243.57
Other Operating Activities
15.149.515.8-7.72-34.374.91
Change in Accounts Receivable
----300-300
Change in Accounts Payable
3.046.041.81-7.582.370.82
Change in Unearned Revenue
-126.14-135.42-36.52-159.56-35.92348.16
Change in Other Net Operating Assets
-13.28-1.64-75.5150.68-14.8362.28
Operating Cash Flow
-359.38-345.1-347.25-149.222.53-66.27
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13.39-14.95-8.95-33.73-48.95-46.81
Cash Acquisitions
-0.08-0.08---0.62
Investment in Securities
202.93-106.41193.95105.57-412.39-247.95
Investing Cash Flow
189.46-121.44185.0171.84-461.34-294.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
---0.49-2.25-2.29-2.12
Net Debt Issued (Repaid)
93.89--0.49-2.25-2.29-2.12
Issuance of Common Stock
14.62478.058.22278.7114.07767.08
Other Financing Activities
-0.81----0.19-8.82
Financing Cash Flow
107.69478.057.74276.45111.59756.14

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-62.2311.51-154.5199.09-327.22395.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-372.77-360.05-356.19-182.93-26.42-113.08
Free Cash Flow Growth
------
Free Cash Flow Margin
-238.90%-257.65%-560.77%-48.43%-43.38%-218.11%
Free Cash Flow Per Share
-3.61-3.64-4.33-2.37-0.38-1.76
Levered Free Cash Flow
-241.84-220.31-156.52-50.36138.32-335.34
Unlevered Free Cash Flow
-241.94-220.31-156.52-50.36138.32-335.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.57-0.030.160.380.57
Change in Working Capital
-136.38-131.02-110.22-116.46251.63111.25
SEC Filings: 10-K · 10-Q